Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMP for Sport

This article was originally published in The Tan Sheet

Executive Summary

Manufacturer Century Foods International became the first firm to receive certification under NSF International's recently announced GMP for Sport program, according to NSF. The GMP program "supports" NSF's Athletic Banned Substances Certification Program but also is an independent registration, the firm states. Forsyth, Missouri-based National Enzyme also received GMP for Sport certification, according to the NSF website. Additionally, the addition of Infinty2's InfiAid to the Athletic Banned Substances Program Certification list also was finalized ("1The Tan Sheet" July 24, 2006, p.5)...

You may also be interested in...



NSF Banned Athletic Substances Program Gains International Momentum

The partnership between the Canadian Centre for Ethics in Sport (CCES) and third-party testing firm NSF International has drawn the attention of several European countries, according to NSF's Kathy Jordan

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099631

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel